0.6185
price down icon10.75%   -0.0745
 
loading
Precedente Chiudi:
$0.693
Aprire:
$0.6997
Volume 24 ore:
1.07M
Relative Volume:
0.77
Capitalizzazione di mercato:
$43.98M
Reddito:
$391.70K
Utile/perdita netta:
$-52.34M
Rapporto P/E:
-0.8247
EPS:
-0.75
Flusso di cassa netto:
$-45.92M
1 W Prestazione:
+12.45%
1M Prestazione:
+96.66%
6M Prestazione:
-15.75%
1 anno Prestazione:
-41.65%
Intervallo 1D:
Value
$0.6097
$0.6999
Intervallo di 1 settimana:
Value
$0.56
$0.7331
Portata 52W:
Value
$0.2425
$1.47

Ovid Therapeutics Inc Stock (OVID) Company Profile

Name
Nome
Ovid Therapeutics Inc
Name
Telefono
212-776-4381
Name
Indirizzo
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Name
Dipendente
23
Name
Cinguettio
@OvidRx
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
OVID's Discussions on Twitter

Confronta OVID con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OVID
Ovid Therapeutics Inc
0.6185 49.28M 391.70K -52.34M -45.92M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-18 Downgrade Oppenheimer Outperform → Perform
2024-04-30 Iniziato B. Riley Securities Buy
2024-04-29 Iniziato H.C. Wainwright Buy
2024-04-05 Iniziato Wedbush Outperform
2023-12-21 Iniziato BTIG Research Buy
2023-10-13 Iniziato Oppenheimer Outperform
2021-04-20 Downgrade Cantor Fitzgerald Buy → Neutral
2021-03-03 Downgrade RBC Capital Mkts Outperform → Sector Perform
2020-12-02 Downgrade Citigroup Buy → Neutral
2020-12-02 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2019-09-04 Iniziato RBC Capital Mkts Outperform
2018-04-20 Iniziato Ladenburg Thalmann Buy
Mostra tutto

Ovid Therapeutics Inc Borsa (OVID) Ultime notizie

pulisher
Jul 25, 2025

Ovid Therapeutics Inc. Stock Analysis and ForecastFree Market Dynamics Reports - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Ovid Therapeutics Sells Ganaxolone Royalty Rights for $7M to Immedica Pharma - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Ovid Therapeutics Inc. stock priceConsistently profitable trades - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Why Ovid Therapeutics Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

Is Ovid Therapeutics Inc. a good long term investmentLightning-fast capital gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Ovid Therapeutics shares rise 4.29% premarket after announcing participation in the BTIG Virtual Biotechnology Conference. - AInvest

Jul 24, 2025
pulisher
Jul 23, 2025

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

12 Best Penny Stocks Under $1 to Buy Now - Insider Monkey

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Ovid Therapeutics Inc. stockBreakout profit opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Ovid Therapeutics' Strategic Position in the Seizure and CNS Disorder Market: Pipeline Innovation and Partnership Potential - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference | OVID Stock News - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Brain Medicine Developer Ovid Therapeutics Reveals Latest Progress at Major BTIG Biotech Conference - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

July 2025's Top Penny Stocks To Watch - simplywall.st

Jul 22, 2025
pulisher
Jul 22, 2025

Ovid Therapeutics Stock Soars 13.88% on Investor Optimism - AInvest

Jul 22, 2025
pulisher
Jul 19, 2025

Ovid Therapeutics (NASDAQ:OVID) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

Ovid Therapeutics (NASDAQ:OVID) Stock Rating Upgraded by Wall Street Zen - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

What makes Ovid Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - beatles.ru

Jul 18, 2025
pulisher
Jul 17, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Jul 17, 2025
pulisher
Jul 17, 2025

Ovid Therapeutics Surges 25% Amid Analyst Hype and Strategic Pipeline Progress - AInvest

Jul 17, 2025
pulisher
Jul 16, 2025

Oliveda International, Inc. (OLVI) Announces Over 70% Growth in the First Half of 2025 - Yahoo.co

Jul 16, 2025
pulisher
Jul 15, 2025

How Ovid Therapeutics Inc. stock performs during market volatilityTop Rated Trade Entries - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Ovid Therapeutics (NASDAQ:OVID) Stock Price Down 2% – Time to Sell? - Defense World

Jul 15, 2025
pulisher
Jul 11, 2025

Ovid Therapeutics Approves Key Proposals at Annual Meeting - The Globe and Mail

Jul 11, 2025
pulisher
Jul 10, 2025

Local Bounti (LOCL) insider files Form 144 to sell 3,500 shares - Stock Titan

Jul 10, 2025
pulisher
Jun 25, 2025

Ovid Therapeutics Sells Ganaxolone Royalties to Immedica - TipRanks

Jun 25, 2025

Ovid Therapeutics Inc Azioni (OVID) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):